ACCURAY INC (ARAY): Results of Operations and Financial Condition
ACCURAY INC (ARAY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Accuray Reports Fourth Quarter and Fiscal 2026 Financial Results MADISON, Wisconsin, August 19, 2026 — Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2026 , ended June 30, 2026 . Key Highlights ● The Company’s t
How this was made
The 30-second read
Why it matters
The earnings release signals short‑term pressure but longer‑term upside if transformation succeeds.
Market read
First‑report earnings data for Accuray, a mid‑cap med‑tech firm, providing actionable insight for traders.
What to watch
Financing deal with TCW may provide liquidity for strategic acquisitions not yet disclosed.
Fourth-quarter revenue fell 21 percent as product revenue and orders declined, while service revenue grew 6 percent and gross margin improved to 34.8 percent; Accuray provided no formal fiscal 2027 revenue or Adjusted EBITDA guidance.
Fourth-quarter product revenue declined 42 percent and gross product orders declined to $37.7 million, driving a 21 percent decline in total net revenue and a 27 percent lower backlog. Service revenue growth, gross-margin expansion, lower operating expenses, and higher Adjusted EBITDA offset part of the demand weakness, but the company withheld formal fiscal 2027 revenue and Adjusted EBITDA guidance.
Key metrics
as reported| Metric | Value | q/q | y/y |
|---|---|---|---|
| Total net revenue, fourth quarter of fiscal 2026GAAP | $100.9 million | – | decrease of 21 percent |
| Total net revenue, fiscal 2026GAAP | $401.9 million | – | decrease of 12 percent |
| Product revenue, fourth quarter of fiscal 2026GAAP | $40.8 million | – | decrease of 42 percent |
| Product revenue, fiscal 2026GAAP | $172.7 million | – | decrease of 27 percent |
| Service revenue, fourth quarter of fiscal 2026GAAP | $60.1 million | – | increase of 6 percent |
| Service revenue, fiscal 2026GAAP | $229.2 million | – | increase of 4 percent |
| Gross profit, fourth quarter of fiscal 2026GAAP | $35.1 million, or 34.8 percent of net revenue | – | – |
| Gross profit, fiscal 2026GAAP | $111.5 million, or 27.7 percent of net revenue | – | – |
| Operating expenses, fourth quarter of fiscal 2026GAAP | $29.6 million | – | decrease of 15 percent |
| Operating expenses excluding restructuring charges, fourth quarter of fiscal 2026other | operating expenses would have decreased by $5.9 million or 17 percent | – | decrease of $5.9 million or 17 percent |
| Operating expenses, fiscal 2026GAAP | $137.9 million | – | decrease of 1 percent |
| Operating expenses excluding restructuring charges, fiscal 2026other | operating expenses would have decreased by $17.4 million or 13 percent | – | decrease of $17.4 million or 13 percent |
| Income from operations, fourth quarter of fiscal 2026GAAP | $5.5 million | – | – |
| Loss from operations, fiscal 2026GAAP | $(26.4) million | – | – |
| Net loss, fourth quarter of fiscal 2026GAAP | $1.9 million | – | – |
| Net loss per diluted share, fourth quarter of fiscal 2026GAAP | $(0.02) per diluted share | – | – |
| GAAP net loss, fiscal 2026GAAP | $49.2 million | – | – |
| Net loss per diluted share, fiscal 2026GAAP | $(0.40) per diluted share | – | – |
| Adjusted EBITDA, fourth quarter of fiscal 2026non-GAAP | $12.9 million | – | – |
| Adjusted EBITDA, fiscal 2026non-GAAP | $10.6 million | – | – |
| Gross product orders, fourth quarter of fiscal 2026other | $37.7 million | – | – |
| Gross product orders, fiscal 2026other | $191.9 million | – | – |
| Net orders, fourth quarter of fiscal 2026other | $(2.9) million | – | – |
| Net orders, fiscal 2026other | $58.2 million | – | – |
| Book to bill ratio, fourth quarter of fiscal 2026other | 0.9 | – | – |
| Book to bill ratio, fiscal 2026other | 1.1 | – | – |
| Order backlog as of June 30, 2026other | $312.5 million | – | approximately 27 percent lower than the end of the prior fiscal year fourth quarter |
| Restructuring charges, fourth quarter of fiscal 2026GAAP | $0.7 million | – | – |
| Restructuring charges, fiscal 2026GAAP | $16.2 million | – | – |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| ProductsProduct demand in certain regions remained impacted by geopolitical developments and tariff uncertainty. | $40.8 million for the fourth quarter of fiscal 2026; $172.7 million for fiscal 2026 | – | decrease of 42 percent in the fourth quarter; decrease of 27 percent for fiscal 2026 |
| ServicesContinued momentum and a stable foundation for profitable growth in the recurring revenue business. | $60.1 million for the fourth quarter of fiscal 2026; $229.2 million for fiscal 2026 | – | increase of 6 percent in the fourth quarter; increase of 4 percent for fiscal 2026 |
Fiscal 2027 outlook
- NoteThe company is not providing formal revenue or Adjusted EBITDA guidance for fiscal 2027 at this time.
- NoteThe company expects continued growth in service revenue.
- NoteThe company expects improved service margins driven by pricing optimization and operational efficiencies.
- NoteThe company expects ongoing operating expense discipline and continued benefits from transformation initiatives.
What drove it
- The transformation plan delivered more than $20 million of cost and margin improvement during fiscal 2026, exceeding the original target of $12 million.
- Fourth-quarter gross margin was 34.8 percent, compared with 30.6 percent in the prior fiscal-year fourth quarter.
- Service revenue increased 6 percent year-over-year in the fourth quarter and 4 percent for fiscal 2026.
- Management cited pricing optimization and operational efficiencies as expected drivers of improved service margins.
- The company expanded strategic partnerships across imaging, software, engineering, adaptive therapy, research, and customer support.
- Management said customer engagement at ESTRO 2026 supported a meaningful increase in qualified commercial opportunities.
Concerns
- Total net revenue declined 21 percent in the fourth quarter and 12 percent for fiscal 2026.
- Product revenue declined 42 percent in the fourth quarter and 27 percent for fiscal 2026.
- Fourth-quarter gross product orders were $37.7 million, compared with $84.7 million, and fourth-quarter net orders were $(2.9) million.
- Order backlog was $312.5 million, approximately 27 percent lower than the end of the prior fiscal year fourth quarter.
- Fiscal 2026 gross margin was 27.7 percent, compared with 32.1 percent in the prior fiscal year period.
- Fiscal 2026 GAAP net loss was $49.2 million, compared with a net loss of $1.6 million in the prior fiscal year period.
- Fiscal 2026 Adjusted EBITDA was $10.6 million, compared with $28.3 million in the prior fiscal year period.
- The company cited geopolitical uncertainty, tariff pressures, conditions in China and the Middle East, and broader macroeconomic factors as reasons for withholding formal fiscal 2027 revenue and Adjusted EBITDA guidance.
What to watch
- Whether service revenue continues to grow and whether pricing optimization and operational efficiencies improve service margins.
- The pace of product demand recovery in regions affected by geopolitical developments and tariff uncertainty.
- Gross orders, net orders, book-to-bill ratio, and conversion of the $312.5 million order backlog to revenue.
- Execution of the transformation plan following more than $20 million of reported fiscal 2026 cost and margin improvement.
- The effects of the TCW Asset Management financing transaction on liquidity, leverage, and covenant compliance through December 2027.
- Whether Accuray resumes formal fiscal 2027 revenue and Adjusted EBITDA guidance as geopolitical and trade-policy conditions develop.
Balance sheet and cash flow
- Total cash, cash equivalents, and short-term restricted cash were $41.2 million as of June 30, 2026, an increase of $2.7 million from March 31, 2026.
- Cash and cash equivalents were $40.6 million as of June 30, 2026, compared with $57.4 million as of June 30, 2025.
- Restricted cash was $0.6 million as of June 30, 2026, compared with $0.6 million as of June 30, 2025; noncurrent restricted cash was $7.5 million, compared with $4.1 million.
- Short-term debt, net was $1.5 million as of June 30, 2026, compared with $12.7 million as of June 30, 2025.
- Long-term debt, net was $146.4 million as of June 30, 2026, compared with $123.8 million as of June 30, 2025.
- The company announced a comprehensive financing transaction with TCW Asset Management that it said strengthens liquidity, reduces leverage, provides relief for certain covenants through December 2027, and enhances financial flexibility.
- Operating cash flow and free cash flow were not reported.
Analysis
Accuray closed fiscal 2026 with sharply lower fourth-quarter revenue, driven by products. Total net revenue was $100.9 million, down 21 percent year-over-year, as product revenue fell 42 percent to $40.8 million. Service revenue increased 6 percent to $60.1 million, continuing the recurring-business growth cited by management. For the full year, total net revenue decreased 12 percent to $401.9 million as product revenue decreased 27 percent while service revenue increased 4 percent.
The order indicators reinforce the product-demand pressure. Fourth-quarter gross product orders were $37.7 million compared with $84.7 million in the prior-year quarter, and net orders were $(2.9) million compared with $45.3 million. The fourth-quarter book-to-bill ratio was 0.9 versus 1.2, while backlog ended the year at $312.5 million, approximately 27 percent below the prior fiscal-year fourth-quarter level. Management linked regional product demand weakness to geopolitical developments and tariff uncertainty.
Profitability improved within the fourth quarter despite lower revenue. Gross margin rose to 34.8 percent from 30.6 percent, operating expenses declined 15 percent to $29.6 million, and Adjusted EBITDA increased to $12.9 million from $9.4 million. The company reported $0.7 million of fourth-quarter restructuring charges. For the full year, however, gross margin declined to 27.7 percent from 32.1 percent, GAAP net loss expanded to $49.2 million from $1.6 million, and Adjusted EBITDA declined to $10.6 million from $28.3 million. Fiscal-year operating expenses included $16.2 million of restructuring charges, while the company said its transformation plan delivered more than $20 million of cost and margin improvement.
Liquidity and financing are central to the fiscal 2027 setup. Total cash, cash equivalents, and short-term restricted cash were $41.2 million at June 30, 2026, up $2.7 million from March 31, 2026. Long-term debt, net was $146.4 million, compared with $123.8 million at June 30, 2025. Accuray said its TCW Asset Management financing transaction strengthens liquidity, reduces leverage, and provides relief for certain covenants through December 2027.
Management expects service revenue growth, better service margins, operating expense discipline, and continued transformation benefits in fiscal 2027. It did not provide formal revenue or Adjusted EBITDA guidance, citing uncertainty around geopolitical developments, international trade policy, tariff impacts, China, the Middle East, and macroeconomic conditions. The core figures to monitor are service growth and margins against the continuing decline in product revenue, orders, and backlog.
Management, verbatim
Despite ongoing geopolitical uncertainty, tariff pressures, and market volatility, we remained focused on the factors within our control and successfully executed against the transformation initiatives we introduced earlier in the fiscal year.
Steve LaNeve, President and Chief Executive Officer
While product demand in certain regions remained impacted by geopolitical developments and tariff uncertainty, we continued to expand service revenue, improve operating efficiency, and execute our transformation initiatives ahead of expectations.
Ali Pervaiz, Chief Financial Officer
Not in the filing
stated, not guessed- Formal fiscal 2027 revenue guidance
- Formal fiscal 2027 Adjusted EBITDA guidance
- Fiscal 2027 gross-margin guidance
- Fiscal 2027 operating-expense guidance
- Fiscal 2027 tax-rate guidance
- Operating cash flow
- Free cash flow
- Share repurchases
- Dividends
- Non-GAAP EPS
- Prior-quarter revenue, margin, earnings, order, and backlog comparisons
AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
Accuray announced a transformation plan delivering $20 M cost savings and a financing transaction to reduce leverage.
Ticker impact
Accuray Inc. filed an 8‑K reporting Q4 and FY 2026 results, showing a 21% revenue decline and a net loss of $1.9 M.
Potential near‑term downside of 3‑5% pending market reaction; longer‑term support if cost cuts sustain margins.
Revenue decline and loss are material new data; financing transaction improves balance sheet, creating a mixed outlook.
Market effects
Highlights challenges in medical device sector with demand pressure but shows importance of cost discipline.
U.S. med‑tech investors may reassess exposure to companies with similar revenue profiles.
Limited to U.S. listed med‑tech space; no broader macro impact.
Counterpoint
Cost improvements could accelerate margin recovery, making the stock a buy on valuation dip.
Key entities
- ExecutiveSteve LaNeve
President and CEO of Accuray
- ExecutiveAli Pervaiz
Chief Financial Officer of Accuray
